Vasorin promotes proliferation and migration via STAT3 signaling and acts as a promising therapeutic target of hepatocellular carcinoma
Cellular Signalling · 2023-10 · 110 · 110809
DOI: 10.1016/j.cellsig.2023.110809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2023-10. Verfasst von Fengjie Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Guangxi Medical University, Nanning 530021, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Abnormal expression of Vasorin (VASN) is related to many types of cancer, but the signaling pathway and mechanism of how VASN contributes to the carcinogenesis of hepatocellular carcinoma (HCC) are poorly understood. Here, we found that VASN was up-regulated in serum/serum exosome and tissues of HCC patients. The expression of VASN in serum improve the detection rate of HCC in alpha-fetoprotein-negative HCC patients. Immunohistochemistry revealed that VASN was highly expressed in HCC tissues and associated with different stages of HCC. Noticeably, when serum VASN combined with α-fetoprotein, the area under the curve (AUC), sensitivity, and specificity of HCC patients compared with healthy patients reached 0.918 (95% CI: 0.869-0.967, P < 0.001), 90.91%, and 90.20%, respectively. VASN knockout HCC cells were obtained by CRISPR/Cas9 and a VASN-specific monoclonal antibody was prepared by hybridoma technology. Knockout of VASN or the addition of VASN-specific monoclonal antibody suppressed the proliferation and migration of HCC. Mechanistically, VASN promote the proliferation and migration of HCC by regulating the phosphorylation of STAT3 and the expression of downstream genes CCND1 and MMP2. In conclusion, our findings suggest that VASN plays a crucial role in the activation of STAT3 signaling pathway in HCC, which is a promising target for the diagnosis and therapy of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Guangxi Medical University, Nanning 530021, China.
- Laboratory Animal Center, Guangxi Medical University, Nanning 530021, China.
- Department of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, PA 17033, USA.
- Laboratory Animal Center, Guangxi Medical University, Nanning 530021, China. Electronic address: yanglichao@gxmu.edu.cn.
- School of Public Health, Guangxi Medical University, Nanning 530021, China; Laboratory Animal Center, Guangxi Medical University, Nanning 530021, China; Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Gua…
Zitieren
APA
Wan, F., Li, H., Huang, S., Sun, J., Li, J., Li, Y., Yang, L., & He, M. (2023). Vasorin promotes proliferation and migration via STAT3 signaling and acts as a promising therapeutic target of hepatocellular carcinoma. Cellular Signalling, 110, 110809. https://doi.org/10.1016/j.cellsig.2023.110809
Vancouver
Wan F, Li H, Huang S, Sun J, Li J, Li Y, et al. Vasorin promotes proliferation and migration via STAT3 signaling and acts as a promising therapeutic target of hepatocellular carcinoma. Cellular Signalling. 2023;110:110809. doi:10.1016/j.cellsig.2023.110809
BibTeX
@article{Wan2023,
author = {Wan, Fengjie and Li, Hui and Huang, Shiping and Sun, Junming and Li, Jiafu and Li, Yasi and Yang, Lichao and He, Min},
title = {Vasorin promotes proliferation and migration via STAT3 signaling and acts as a promising therapeutic target of hepatocellular carcinoma},
journal = {Cellular Signalling},
year = {2023},
volume = {110},
pages = {110809},
doi = {10.1016/j.cellsig.2023.110809}
}
EUVIMED